Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TETHYS OIL AB. We currently have 25 research reports from 3 professional analysts.
Frequency of research reports
Research reports on
TETHYS OIL AB
TETHYS OIL AB
GMP FirstEnergy ― UK Energy morning research package
21 Nov 16
Pacific Exploration and Production Corporation (PEN CN) 1,6: BUY, C$68.50; corporate restructuring happened post 3Q16 results | GeoPark Limited (GPRK US)1,6: BUY, US$6.50; 3Q16 results and better than expected 2017 guidance | EnQuest (ENQ LN); SPEC. BUY, £0.50: Production Update | San Leon Energy (SLE LN) (not covered): Sale of Polish assets to Palomar Natural Resources | Tethys Oil (TETY SS)6: Hold; SEK70, New boundaries for Block 3 licence area onshore Oman | Wentworth Resources (WRL LN/NO)1,6: Buy; £0.50, Directors buying shares in the company
The Monthly November 2016
01 Nov 16
Share prices are built on expectations - expectations about all sorts of things, such as a company’s future sales growth, the trend in margins and the profits it can return. Understanding those expectations and how they move is critical to share price formation. Listing rules require quoted companies to update investors on progress relative to expectations. What managements often fail to understand is that many of their key investors do not have access to brokers’ research and, thus, cannot put management statements into context. It is these very investors that can cause shock movements in share prices on announcements in limited trading.
Share price appreciation & 3Q16 production results
19 Oct 16
The company’s share price has appreciated c. 23% in the two and a half months since we initiated coverage with a BUY recommendation and target price of SEK70 on 2nd August 2016. We maintain our target price of SEK70 per share but now have a HOLD recommendation given the shares’ very strong recent performance. Tethys Oil’s share of 3Q16 production, before government take, from Blocks 3 and 4 in Oman was 1,120,764 barrels of oil, implying net production of c. 12, 166 bbl/d for September (FCC GMPe 3Q16 12,640 bbl/d). The September production is slightly below August production of 12,489 bbl/d but slightly above July production of 11,891 bbl/d. This is in line with anticipated month to month fluctuations from Blocks 3 and 4 in Oman.
03 Oct 16
Many commentators realise that the traditional institutional broking model is no longer sustainable. However, the reduction in the quantity of non-corporate coverage that has already occurred, even before MiFID2 comes into effect, will still come as a shock. The evidence shows that there is no commercial sense in brokers covering non-corporate companies with less that £200,000 daily turnover in their shares.
30 Nov 16
Abzena (ABZA): Interim results indicate happy customers (BUY) | Horizonte Minerals* (HZM): Fund raise completed (CORP) | SacOil* (SAC): Half-year trading statement (CORP) | Revolution Bars (RBG): New openings (BUY) | Amino Technologies* (AMO): Multi operator FUSION roll out (CORP)
Small Cap Breakfast
29 Nov 16
Asia Pacific Investment Partner - the research-driven emerging and frontier markets real estate development business intends to float on AIM and conduct a placing in December RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December. Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.
24 Nov 16
Quixant* (QXT): Gaming gains (CORP) | SCISYS* (SSY): Bringing good news from Germany (CORP) | Hayward Tyler Group*: Contract wins (CORP) | Sound Energy (SOU): TE-7 flow rate and fund raise (BUY) | Water Intelligence* (WATR): Growth and improving returns in a defensive market (CORP) | Imaginatik* (IMTK): Interim trading update (CORP)
Small Cap Breakfast
28 Nov 16
Warpaint London—Schedule one update. Raising £2.5m at 97p. Expected mkt cap £62.6m vs revenues of £22.3m Walls & Futures REIT — Has raised £1m at £1 to acquire, refurbish or develop residential properties in the UK . Due to arrive on ISDX on 29 November Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December. Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.